Cargando…
Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia
BACKGROUND: Because of the high risk of thrombotic complications (TCs) during SARS-CoV-2 infection, several scientific societies have proposed to increase the dose of preventive anticoagulation, although arguments in favor of this strategy are inconsistent. RESEARCH QUESTION: What is the incidence o...
Autores principales: | Tacquard, Charles, Mansour, Alexandre, Godon, Alexandre, Godet, Julien, Poissy, Julien, Garrigue, Delphine, Kipnis, Eric, Rym Hamada, Sophie, Mertes, Paul Michel, Steib, Annick, Ulliel-Roche, Mathilde, Bouhemad, Bélaïd, Nguyen, Maxime, Reizine, Florian, Gouin-Thibault, Isabelle, Besse, Marie Charlotte, Collercandy, Nived, Mankikian, Stefan, Levy, Jerrold H., Gruel, Yves, Albaladejo, Pierre, Susen, Sophie, Godier, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832130/ https://www.ncbi.nlm.nih.gov/pubmed/33465342 http://dx.doi.org/10.1016/j.chest.2021.01.017 |
Ejemplares similares
-
Anticoagulation in COVID-19: not strong for too long?
por: Tacquard, Charles, et al.
Publicado: (2021) -
Reply to the authors of “Age-adjusted D-dimer cut-off levels to exclude venous thromboembolism in COVID-19 patients”()
por: Godon, Alexandre, et al.
Publicado: (2021) -
Response
por: Tacquard, Charles, et al.
Publicado: (2021) -
Response
por: Tacquard, Charles, et al.
Publicado: (2021) -
Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring
por: Susen, Sophie, et al.
Publicado: (2020)